help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arscott, P. L.
Right arrow Articles by Baker, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arscott, P. L.
Right arrow Articles by Baker, J. R., Jr.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOHEXIMIDE
Endocrinology Vol. 138, No. 11 5019-5027
Copyright © 1997 by The Endocrine Society


ARTICLES

Fas (APO-1, CD95)-Mediated Apoptosis in Thyroid Cells Is Regulated by a Labile Protein Inhibitor1

Patricia L. Arscott, Jill Knapp, Michal Rymaszewski, Jeffrey L. Bartron, James D. Bretz, Norman W. T hompson and James R. Baker, Jr.

Departments of Medicine (P.L.A., J.K., M.R., J.L.B., J.D.B., J.R.B.) and Surgery (N.W.T.), University of Michigan Medical School, Ann Arbor, Michigan 48109-0666

Address all correspondence and requests for reprints to: James R. Baker, Jr., University of Michigan Medical School, 1520 MSRB I, Ann Arbor, Michigan 48109-0666.

To determine whether thyroid cell apoptosis observed in autoimmune thyroid disease could be related to activation of the Fas pathway, we examined the expression and function of Fas on thyroid follicular cells in vitro. Fas messenger RNA was found to be present using two different techniques and was expressed at equal levels in thyrocytes cultured either in the presence or absence of TSH. Fas antigen protein expression was demonstrated by Western blot of thyroid cell lysates and by immunohistochemical staining of thyrocytes, and the amount of Fas protein present did not appear to vary regardless of culture conditions. Despite expressing substantial amounts of Fas protein, thyrocytes treated with anti-Fas monoclonal antibody failed to undergo apoptosis. The addition of either interferon-{gamma} or interleukin-1ß to the anti-Fas-treated cell cultures also did not promote apoptotic signaling through this pathway. In contrast, the concomitant administration of cycloheximide allowed the induction of apoptosis through the activation of Fas in thyrocytes. These results suggest that Fas is constitutively expressed in thyrocytes, but that the induction of apoptosis through the Fas pathway is blocked by a labile protein inhibitor.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
S. Fountoulakis, G. Vartholomatos, N. Kolaitis, S. Frillingos, G. Philippou, and A. Tsatsoulis
Differential expression of Fas system apoptotic molecules in peripheral lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis.
Eur. J. Endocrinol., June 1, 2008; 158(6): 853 - 859.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z.-X. Du, H.-Q. Wang, H.-Y. Zhang, and D.-X. Gao
Involvement of Glyceraldehyde-3-Phosphate Dehydrogenase in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Death of Thyroid Cancer Cells
Endocrinology, September 1, 2007; 148(9): 4352 - 4361.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. S. Mitsiades, V. Poulaki, G. Fanourakis, E. Sozopoulos, D. McMillin, Z. Wen, G. Voutsinas, S. Tseleni-Balafouta, and N. Mitsiades
Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
Clin. Cancer Res., June 15, 2006; 12(12): 3705 - 3712.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. H. Wang, Z. Cao, J. M. Wolf, M. Van Antwerp, and J. R. Baker Jr.
Death Ligand Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Inhibits Experimental Autoimmune Thyroiditis
Endocrinology, November 1, 2005; 146(11): 4721 - 4726.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. Mezosi, S. H. Wang, S. Utsugi, L. Bajnok, J. D. Bretz, P. G. Gauger, N. W. Thompson, and J. R. Baker Jr.
Induction and Regulation of Fas-Mediated Apoptosis in Human Thyroid Epithelial Cells
Mol. Endocrinol., March 1, 2005; 19(3): 804 - 811.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Mezosi, S. H. Wang, S. Utsugi, L. Bajnok, J. D. Bretz, P. G. Gauger, N. W. Thompson, and J. R. Baker Jr.
Interleukin-1{beta} and Tumor Necrosis Factor (TNF)-{alpha} Sensitize Human Thyroid Epithelial Cells to TNF-Related Apoptosis-Inducing Ligand-Induced Apoptosis through Increases in Procaspase-7 and Bid, and the Down-Regulation of p44/42 Mitogen-Activated Protein Kinase Activity
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 250 - 257.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Mezosi, H. Yamazaki, J. D. Bretz, S. H. Wang, P. L. Arscott, S. Utsugi, P. G. Gauger, N. W. Thompson, and J. R. Baker Jr.
Aberrant Apoptosis in Thyroid Epithelial Cells from Goiter Nodules
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4264 - 4272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. Poulaki, C. S. Mitsiades, V. Kotoula, S. Tseleni-Balafouta, A. Ashkenazi, D. A. Koutras, and N. Mitsiades
Regulation of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Thyroid Carcinoma Cells
Am. J. Pathol., August 1, 2002; 161(2): 643 - 654.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. H. Wang, J. D. Bretz, E. Phelps, E. Mezosi, P. L. Arscott, S. Utsugi, and J. R. Baker Jr.
A Unique Combination of Inflammatory Cytokines Enhances Apoptosis of Thyroid Follicular Cells and Transforms Nondestructive to Destructive Thyroiditis in Experimental Autoimmune Thyroiditis
J. Immunol., March 1, 2002; 168(5): 2470 - 2474.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Feldkamp, E. Pascher, M. Schott, P. Goretzki, J. Seissler, and W. A. Scherbaum
Soluble Fas Is Increased in Hyperthyroidism Independent of the Underlying Thyroid Disease
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4250 - 4253.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Tourneur, B. Malassagne, F. Batteux, M. Fabre, S. Mistou, E. Lallemand, P. Lores, and G. Chiocchia
Transgenic Expression of CD95 Ligand on Thyroid Follicular Cells Confers Immune Privilege upon Thyroid Allografts
J. Immunol., August 1, 2001; 167(3): 1338 - 1346.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. N. Nikiforova, J. R. Stringer, R. Blough, M. Medvedovic, J. A. Fagin, and Y. E. Nikiforov
Proximity of Chromosomal Loci That Participate in Radiation-Induced Rearrangements in Human Cells
Science, October 6, 2000; 290(5489): 138 - 141.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Francavilla, P. D’Abrizio, N. Rucci, G. Silvano, G. Properzi, E. Straface, G. Cordeschi, S. Necozione, L. Gnessi, M. Arizzi, et al.
Fas and Fas Ligand Expression in Fetal and Adult Human Testis with Normal or Deranged Spermatogenesis
J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2692 - 2700.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
N. Mitsiades, V. Poulaki, S. Tseleni-Balafouta, D. A. Koutras, and I. Stamenkovic
Thyroid Carcinoma Cells Are Resistant to FAS-mediated Apoptosis But Sensitive to Tumor Necrosis Factor-related Apoptosis-inducing Ligand
Cancer Res., August 1, 2000; 60(15): 4122 - 4129.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
S. M. Quirk, R. M. Harman, S. C. Huber, and R. G. Cowan
Responsiveness of Mouse Corpora Luteal Cells to Fas Antigen (CD95)-Mediated Apoptosis
Biol Reprod, July 1, 2000; 63(1): 49 - 56.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
F. Batteux, P. Lores, D. Bucchini, and G. Chiocchia
Transgenic Expression of Fas Ligand on Thyroid Follicular Cells Prevents Autoimmune Thyroiditis
J. Immunol., February 15, 2000; 164(4): 1681 - 1688.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. L. Vickers, R. G. Cowan, R. M. Harman, D. A. Porter, and S. M. Quirk
Expression and Activity of the Fas Antigen in Bovine Ovarian Follicle Cells
Biol Reprod, January 1, 2000; 62(1): 54 - 61.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
D. A. Porter, S. L. Vickers, R. G. Cowan, S. C. Huber, and S. M. Quirk
Expression and Function of Fas Antigen Vary in Bovine Granulosa and Theca Cells During Ovarian Follicular Development and Atresia
Biol Reprod, January 1, 2000; 62(1): 62 - 66.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
P. L. Arscott, T. Stokes, A. Myc, T. J. Giordano, N. W. Thompson, and J. R. Baker Jr.
Fas (CD95) Expression is Up-Regulated on Papillary Thyroid Carcinoma
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4246 - 4252.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. D. Bretz, P. L. Arscott, A. Myc, and J. R. Baker Jr.
Inflammatory Cytokine Regulation of Fas-mediated Apoptosis in Thyroid Follicular Cells
J. Biol. Chem., September 3, 1999; 274(36): 25433 - 25438.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Knauf, R. Elisei, D. Mochly-Rosen, T. Liron, X.-N. Chen, R. Gonsky, J. R. Korenberg, and J. A. Fagin
Involvement of Protein Kinase Cepsilon (PKCepsilon ) in Thyroid Cell Death. A TRUNCATED CHIMERIC PKCepsilon CLONED FROM A THYROID CANCER CELL LINE PROTECTS THYROID CELLS FROM APOPTOSIS
J. Biol. Chem., August 13, 1999; 274(33): 23414 - 23425.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Bretz, M. Rymaszewski, P. L. Arscott, A. Myc, K. B. Ain, N. W. Thompson, and J. R. Baker Jr.
TRAIL Death Pathway Expression and Induction in Thyroid Follicular Cells
J. Biol. Chem., August 13, 1999; 274(33): 23627 - 23632.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Hiromatsu, T. Hoshino, H. Yagita, M. Koga, S. Sakisaka, J. Honda, D. Yang, N. Kayagaki, K. Okumura, and K. Nonaka
Functional Fas Ligand Expression in Thyrocytes from Patients with Graves' Disease
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2896 - 2902.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Mitsiades, V. Poulaki, G. Mastorakos, S. Tseleni-Balafouta, V. Kotoula, D. A. Koutras, and M. Tsokos
Fas Ligand Expression in Thyroid Carcinomas: A Potential Mechanism of Immune Evasion
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2924 - 2932.
[Abstract] [Full Text]


Home page
BloodHome page
N. Moulian, C. Renvoize, C. Desodt, A. Serraf, and S. Berrih-Aknin
Functional Fas Expression in Human Thymic Epithelial Cells
Blood, April 15, 1999; 93(8): 2660 - 2670.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. H. Wang, R. J. Koenig, T. J. Giordano, A. Myc, N. W. Thompson, and J. R. Baker Jr.
1{alpha},25-Dihydroxyvitamin D3 Up-Regulates Bcl-2 Expression and Protects Normal Human Thyrocytes from Programmed Cell Death
Endocrinology, April 1, 1999; 140(4): 1649 - 1656.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
F. Batteux, L. Tourneur, H. Trebeden, J. Charreire, and G. Chiocchia
Gene Therapy of Experimental Autoimmune Thyroiditis by In Vivo Administration of Plasmid DNA Coding for Fas Ligand
J. Immunol., January 1, 1999; 162(1): 603 - 608.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. M. Quirk, D. A. Porter, S. C. Huber, and R. G. Cowan
Potentiation of Fas-Mediated Apoptosis of Murine Granulosa Cells by Interferon-{gamma}, Tumor Necrosis Factor-{alpha}, and Cycloheximide
Endocrinology, December 1, 1998; 139(12): 4860 - 4869.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Tamura, H. Kimura, T. Koji, T. Tominaga, K. Ashizawa, T. Kiriyama, N. Yokoyama, T. Yoshimura, K. Eguchi, P. K. Nakane, et al.
Role of Apoptosis of Thyrocytes in a Rat Model of Goiter. A Possible Involvement of Fas System
Endocrinology, August 1, 1998; 139(8): 3646 - 3653.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Mitsiades, V. Poulaki, V. Kotoula, G. Mastorakos, S. Tseleni-Balafouta, D. A. Koutras, and M. Tsokos
Fas/Fas Ligand Up-Regulation and BCL-2 Down-Regulation May Be Significant in the Pathogenesis of Hashimoto's Thyroiditis
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2199 - 2203.
[Abstract] [Full Text]


Home page
ScienceHome page
T. A. Stokes, M. Rymaszewski, P. L. Arscott, S. H. Wang, J. D. Bretz, J. Bartron, J. R. Baker Jr.;, P. Fiedler, C. E. Schaetzlein, H. Eibel;, et al.
Constitutive Expression of FasL in Thyrocytes
Science, March 27, 1998; 279(5359): 2015 - 2015.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society